UT Southwestern Medical Center
Radiation Oncology residency · Dallas, TX · Program website
This program's roster hasn't been collected yet, so there's no list of its own faculty and papers. Below is The University of Texas Southwestern Medical Center's research in radiation oncology, which the program shares with other departments and affiliated hospitals.
About The University of Texas Southwestern Medical Centerinstitution-wide radiation oncology research
Radiation Oncology publications from The University of Texas Southwestern Medical Center and affiliated institutions, since 2022. Updated 2026-11-06; refreshed daily.
400
works per year
8th of 47 radiation oncology residency programs
+21.4%
2-year growth
12th of 47 radiation oncology residency programs
23.5%
in top 10% of field (works before 2025)
18th of 47 radiation oncology residency programs
45.0%
cited above world average
19th of 47 radiation oncology residency programs
Works per year · * 2026 so far
Oncology · 1,287Radiology, Nuclear Medicine and Imaging · 765
Radiation Oncology research topics at The University of Texas Southwestern Medical Center
Papers in the window; each links to the list on OpenAlex.
- Cancer Immunotherapy and Biomarkers 251
- Advanced MRI Techniques and Applications 151
- Pancreatic and Hepatic Oncology Research 140
- CAR-T cell therapy research 122
- Cardiac Imaging and Diagnostics 101
- Cutaneous Melanoma Detection and Management 68
- Radiomics and Machine Learning in Medical Imaging 61
- Renal cell carcinoma treatment 60
Most cited at The University of Texas Southwestern Medical Center since 2024
All radiation oncology papers there on OpenAlex
- Colon Cancer, Version 3.2024, NCCN Clinical Practice Guidelines in OncologyAl B. Benson et al. · Journal of the National Comprehensive Cancer Network · 2024 · PubMed · cited 406
- NCCN Guidelines® Insights: Rectal Cancer, Version 3.2024Al B. Benson et al. · Journal of the National Comprehensive Cancer Network · 2024 · PubMed · cited 312
- Modulation of the tumor microenvironment and mechanism of immunotherapy-based drug resistance in breast cancerMoumita Kundu et al. · Molecular Cancer · 2024 · PubMed · cited 273
- Gastric Cancer, Version 2.2025, NCCN Clinical Practice Guidelines In OncologyJaffer A. Ajani et al. · Journal of the National Comprehensive Cancer Network · 2025 · PubMed · cited 243
- Nivolumab plus ipilimumab versus sunitinib for first-line treatment of advanced renal cell carcinoma: extended 8-year follow-up results of efficacy and safety from the phase III CheckMate 214 trialNizar M. Tannir et al. · Annals of Oncology · 2024 · PubMed · cited 236
- Single-cell and spatial profiling identify three response trajectories to pembrolizumab and radiation therapy in triple negative breast cancerStephen Lawrence Shiao et al. · Cancer Cell · 2024 · PubMed · cited 212
- Immune heterogeneity in small-cell lung cancer and vulnerability to immune checkpoint blockadeBarzin Y. Nabet et al. · Cancer Cell · 2024 · PubMed · cited 196
- The Second International Consensus Guidelines on the Management of BK Polyomavirus in Kidney TransplantationCamille N. Kotton et al. · Transplantation · 2024 · PubMed · cited 195
- NCCN Guidelines® Insights: Melanoma: Cutaneous, Version 2.2024Susan M. Swetter et al. · Journal of the National Comprehensive Cancer Network · 2024 · PubMed · cited 173
- NCCN Guidelines® Insights: Management of Immunotherapy-Related Toxicities, Version 2.2024John A. Thompson et al. · Journal of the National Comprehensive Cancer Network · 2024 · PubMed · cited 171